Incidental vs. non-incidental gallbladder cancer – a hospital-based clinicopathological study
DOI:
https://doi.org/10.15584/ejcem.2024.3.17Keywords:
histopathology, incidental gallbladder carcinoma, non-incidental gallbladder carcinoma, prognosis, radiologyAbstract
Introduction and aim. Most gallbladder cancers (GBCs) are discovered incidentally after routine cholecystectomy. The clinicopathological characteristics and prognostic implications of incidental gallbladder cancer (IGBC) versus non-incidental gallbladder cancer (NIGBC) is not known.
Material and methods. During this study, clinicopathological details compared between incidental and non-incidental GBC groups included age, sex, clinical presentation, preoperative radiological diagnosis, surgical management, and macroscopic and microscopic features. The primary outcome of the study was difference in overall survival (OS) between IGBC and NIGBC.
Results. Among 348 surgically treated patients, 56.6% weren’t preoperatively suspected of GBC. Macroscopic examination showed characteristic thickened gallbladder wall without mass lesion (IGBC) vs. clear mass lesion (NIGBC) on imaging. Interestingly, NIGBC had higher LVI (27% vs. 14%) and T stage (68% T2b/T3 vs. 47% T1b/T2a) despite lower margin involvement (p < 0.001). The OS for all patients was 12.2 months (median). Among patients who underwent surgery with curative intent, the median survival time was 21.4 months. However, within this group, NIGBC cases had a worse median survival (17 months) compared to IGBC cases (21 months).
Conclusion. Rising incidental GBC necessitates routine microscopic examination of all gallbladder specimens. Surgeons in high-risk areas should remain vigilant for GBC in patients with atypical clinical and ultrasound findings. Early detection and curative resection are paramount for long-term survival in gallbladder carcinoma, with IGBC potentially offering a survival benefit regardless of stage or tumor characteristics. Prospective studies including detailed pathology and molecular analysis are needed to confirm this observation.
Supporting Agencies
This research received funding from ICMR in the form of ICMR-Senior Research Fellowship no: No.3/2/2/14/2018/Online OncoFship/NCD-III).Downloads
References
Roa JC, García P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8(1):69. doi: 10.1038/s41572-022-00398-y
Cassese G, Han HS, Yoon YS, et al. Preoperative Assessment and Perioperative Management of Resectable Gallbladder Cancer in the Era of Precision Medicine and Novel Technologies: State of the Art and Future Perspectives. Diagnostics (Basel). 2022;12(7):1630. doi: 10.3390/diagnostics12071630
Nagarajan G, Kundalia K. Should every cholecystectomy specimen be sent for histopathology to identify incidental gall bladder cancer? Indian J Cancer. 2020;57(1):2-3. doi: 10.4103/ijc.IJC_1027_19
Wang Z, Xu Y, Hu D, et al. Laparoscopy Versus Open Reoperation for Incidental Gallbladder Carcinoma After Laparoscopic Cholecystectomy. J Laparoendosc Adv Surg Tech A. 2020;30(7):764-768. doi: 10.1089/lap.2019.0802
Levy AD, Murakata LA, Abbott RM, Rohrmann CA Jr. From the archives of the AFIP. Benign tumors and tumorlike lesions of the gallbladder and extrahepatic bile ducts: radiologic-pathologic correlation. Armed Forces Institute of Pathology. Radiographics. 2002;22(2):387-413. doi: 10.1148/radiographics.22.2.g02mr08387
Fujiwara K, Masatsugu T, Abe A, Hirano T, Sada M. Preoperative diagnoses and identification rates of unexpected gallbladder cancer. PLoS One. 2020;15(9):0239178. doi: 10.1371/journal.pone.0239178
Cavallaro A, Piccolo G, Di Vita M, et al. Managing the incidentally detected gallbladder cancer: algorithms and controversies. Int J Surg. 2014;12(2):108-119. doi: 10.1016/j.ijsu.2014.08.367
Ethun CG, Le N, Lopez-Aguiar AG, et al. Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium. Am Surg. 2017;83(7):679-686.
Kumar A, Ali M, Raj V, et al. Arsenic causing gallbladder cancer disease in Bihar. Sci Rep. 2023;13(1):4259. doi: 10.1038/s41598-023-30898-0
GLOBOCAN 2020. https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. Accessed December 11, 2020.
Subedi R, Dhimal M, Budukh A, et al. Epidemiologic Pattern of Cancer in Kathmandu Valley, Nepal: Findings of Population-Based Cancer Registry, 2018. JCO Glob Oncol. 2021;7:443-452. doi: 10.1200/GO.20.00574
Pandit N, Neupane D, Nalbo D, et al. Resectability and prognosis of gallbladder cancer: a cross-sectional study of 100 cases from a tertiary care centre of Eastern Nepal. Ann Med Surg (Lond). 2023;85(5):1755-1760. doi: 10.1097/MS9.0000000000000699
Rout N, Hota SK, Dash S, Samantaray S, Mallik RN, Agrawal O. Diagnostic Utility of Ultrasound-Guided Fine-Needle Aspiration Cytology in Gall Bladder Lesions: An Experience from a Tertiary Care Cancer Center in Eastern India. J Cytol. 2021;38(3):145-150. doi: 10.4103/JOC.JOC_166_20
Cassese G, Han HS, Yoon YS, et al. Preoperative Assessment and Perioperative Management of Resectable Gallbladder Cancer in the Era of Precision Medicine and Novel Technologies: State of the Art and Future Perspectives. Diagnostics (Basel). 2022;12(7):1630. doi: 10.3390/diagnostics12071630
Fuks D, Regimbeau JM, Le Treut YP, et al. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg. 2011;35(8):1887-1897. doi: 10.1007/s00268-011-1134-3
Jha V, Sharma P, Mandal KA. Incidental gallbladder carcinoma: Utility of histopathological evaluation of routine cholecystectomy specimens. South Asian J Cancer. 2018;7(1):21-23. doi: 10.4103/2278-330X.226802
Darmas B, Mahmud S, Abbas A, Baker AL. Is there any justification for the routine histological examination of straightforward cholecystectomy specimens? Ann R Coll Surg Engl. 2007;89(3):238-241. doi: 10.1308/003588407X168361
Pyo JS, Son BK, Lee HY, Oh IW, Chung KH. Incidental Carcinoma after Cholecystectomy for Benign Disease of the Gallbladder: A Meta-Analysis. J Clin Med. 2020;9(5):1484. doi: 10.3390/jcm9051484
Rammohan A, Cherukuri SD, Sathyanesan J, Palaniappan R, Govindan M. Incidental gall bladder cancers: Are they truly incidental? World J Gastrointest Oncol. 2014;6(12):441-443. doi: 10.4251/wjgo.v6.i12.441
Agarwal AK, Kalayarasan R, Singh S, Javed A, Sakhuja P. All cholecystectomy specimens must be sent for histopathology to detect inapparent gallbladder cancer. HPB (Oxford). 2012;14(4):269-273. doi: 10.1111/j.1477-2574.2012.00443.x
Shih SP, Schulick RD, Cameron JL, et al. Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg. 2007; 245(6):893-901. doi: 10.1097/SLA.0b013e31806beec2
Vega EA, Vinuela E, Sanhueza M, et al. Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator. Eur J Surg Oncol. 2019;45(6):1061-1068. doi: 10.1016/j.ejso.2019.01.013
Alarabiyat M, Raza SS, Isaac J, et al. Incidental gallbladder cancer diagnosis confers survival advantage irrespective of tumour stage and characteristics. World J Gastroenterol. 2022;28(18):1996-2007. doi: 10.3748/wjg.v28.i18.1996
Zaidi MY, Abou-Alfa GK, Ethun CG, et al. Evaluation and management of incidental gallbladder cancer. Chin Clin Oncol. 2019;8(4):37. doi: 10.21037/cco.2019.07.01
Rathanaswamy S, Misra S, Kumar V, et al. Incidentally detected gallbladder cancer- the controversies and algorithmic approach to management. Indian J Surg. 2012;74(3):248-254. doi: 10.1007/s12262-012-0592-7
Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232(4):557-569. doi: 10.1097/00000658-200010000-00011
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
